As per the terms of the pact, both the parties are expected to fund up to five programs a year.
Sanofi-aventis may also host postdoctoral fellows at the company and Sanofi-aventis scientists may also be invited by Stanford faculty to be visiting scholars and to pursue research collaborations at Stanford.
Additionally, Sanofi-aventis will fund an annual research forum that will bring together Sanofi-aventis and Bio-X researchers to share knowledge and perspectives on relevant scientific matters and to discuss research projects funded through the collaboration.
Sanofi-aventis US senior vice president, chief science officer and chief medical officer Paul Chew said Bio-X researchers are exploring novel approaches needed in science today to accelerate the potential for scientific breakthroughs.